Cancer Trials in Paris, France
Conditions / Cancer / Paris, France
Research into Cancer spans multiple therapeutic approaches and trial phases.
94 total trials for this combination
Showing top 10 of 94 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00082433 | Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer | COMPLETED | PHASE3 |
| NCT01459653 | Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor | COMPLETED | — |
| NCT01235962 | A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC) | COMPLETED | PHASE3 |
| NCT01444456 | Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia | COMPLETED | — |
| NCT03899155 | Pan Tumor Rollover Study | RECRUITING | PHASE2 |
| NCT00925600 | Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss | COMPLETED | PHASE3 |
| NCT01986426 | LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab | COMPLETED | PHASE1 |
| NCT01345019 | Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma | COMPLETED | PHASE3 |
| NCT02668250 | Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality | COMPLETED | NA |
| NCT04464226 | Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer | ACTIVE_NOT_RECRUITING | — |